Osiris Therapeutics, Inc. (OSIR) in Focus: Stock Rises 9.13%

Zacks


Osiris Therapeutics, Inc. (OSIR) was a big mover last session, as the company saw its shares jump over 9% on the day. This rise can be attributable to solid volume with far more shares changing hands than in a normal session. This continues the most recent uptrend of the company, as the stock is now up 29.00% in the past one-month time frame.

In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged over the same period. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.

Osiris Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other attractive players in the healthcare industry include Gilead Sciences Inc. (GILD), Myriad Genetics Inc. (MYGN) and ANI Pharmaceuticals, Inc. (ANIP), all carrying a Zacks Rank #1 (Strong Buy)

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>





OSIRIS THERAPEUTICS MD (OSIR): Free Stock Analysis Report

ANI PHARMACEUTICALS INC (ANIP): Free Stock Analysis Report

GILEAD SCIENCES INC (GILD): Free Stock Analysis Report

MYRIAD GENETICS INC (MYGN): Free Stock Analysis Report


Zacks Investment Research

Rates

View Comments (0)